Table 6 MPO expression recorded in the colonic mucosa and submucosa of normal and treated groups.

From: Pharmacological and metabolomic profiles of Musa acuminata wastes as a new potential source of anti-ulcerative colitis agents

Group

MPO expression in the colonic mucosa (% of positive cells/HPF) (mean ± SD)

MPO expression in the colonic mucosa (% of positive cells/HPF) (mean ± SE)

MPO expression in the colonic submucosa (% of positive cells/HPF) (mean ± SD)

MPO expression in the colonic submucosa (% of positive cells/HPF) (mean ± SE)

Negative control

0.20d± 0.42

0.20d ± 0.13

0.10d ± 0.31

0.10d ± 0.10

C+ ve acetic acid 8% (2 ml/rat)

3.30a ± 0.48

3.30a ± 0.15

3.90a ± 0.31

3.90a ± 0.10

Prednisolone

0.80c,d ± 0.63

0.80c,d ± 0.20

0.80c,d ± 0.42

0.80c,d ± 0.13

Musa leaves (250 mg/kg)

3.30a ± 0.67

3.30a ± 0.21

3.40b ± 0.69

3.40b ± 0.22

Musa leaves (500 mg/kg)

2.20b ± 1.13

2.20b ± 0.35

1.30c ± 0.67

1.30c ± 0.21

Musa pseudostem (250 mg/kg)

1.10c ± 0.73

1.10c ± 0.23

1.10b,c ± 0.73

1.10b,c ± 0.29

Musa pseudostem (500 mg/kg)

0.90c ± 0.56

0.90c ± 0.17

0.70c,d ± 0.40

0.70c,d ± 0.15

Musa fruits (250 mg/kg)

1.00c ± 0.47

1.00c ± 0.14

1.00b,c ± 0.66

1.00b,c ± 0.21

Musa fruits (500 mg/kg)

0.50c,d ± 0.52

0.50c,d ± 0.16

0.20d ± 0.42

0.20d ± 0.13

  1. Results are expressed as means of MPO positive cells ± SE.
  2. aSignificantly different from negative control group, bSignificantly different from prednisolone group, cSignificantly different from Musa leaves high dose, d = Significantly different from positive control group.
Back to article page